Obermatt
See Similar Stocks →

Tharimmune

NAQ:THAR · US4327053090
BiotechnologyX-Small

360° View

no current rank
Price/Sales—
Price/Earnings—
Price/Book100
Dividend Yield1
Revenue Growth—
Profit Growth11
Capital Growth81
TSR 52w48
Leverage62
Liquidity1
Refinancing97
Combined—
Analyst Opinions—
Pro Holdings23
Opinion Changes—
Market Pulse21

Profile

CountryUSA
IndustryBiotechnology
SizeX-Small
TypePublic Company
ExchangeNASDAQCM
Founded2017
Employees10
Websitetharimmune.com
ISINUS4327053090
Last UpdateApr 2, 2026
Index & Theme
InflammationCryptocurrencyImmunologyHepatologyWeb3BlockchainFintechChronic DiseasesOncologyDecentralized FinanceBiopharmaBiotechnologyClinical Trials

Description

Canton Strategic Holdings, Inc. focuses on leveraging Canton Coin and supporting the Canton network to advance institutional blockchain adoption and the digitization of financial markets. The company also operates clinical-stage biotech research and…

Similar Stocks

The companies this stock is ranked against.

Compare Tharimmune with its peers
Xencor
NMQ:XNCR
13
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Zymeworks
NSQ:ZYME
43
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Xenon Pharmaceuticals
NMQ:XENE
28
CountryCanada
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
BIOAGE Labs
NSQ:BIOA
23
CountryUSA
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
PepGen
NSQ:PEPG
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
ArriVent BioPharma
NMQ:AVBP
89
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →